[{"address1": "210 Main Street West", "city": "Baudette", "state": "MN", "zip": "56623", "country": "United States", "phone": "218 634 3500", "fax": "218 634 3540", "website": "https://www.anipharmaceuticals.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.", "fullTimeEmployees": 897, "companyOfficers": [{"maxAge": 1, "name": "Mr. Nikhil  Lalwani", "age": 46, "title": "President, CEO & Director", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 2439171, "exercisedValue": 865800, "unexercisedValue": 3627350}, {"maxAge": 1, "name": "Mr. Stephen P. Carey", "age": 53, "title": "Senior VP of Finance & CFO", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 1138453, "exercisedValue": 0, "unexercisedValue": 515953}, {"maxAge": 1, "name": "Ms. Meredith W. Cook J.D.", "age": 50, "title": "Senior VP, General Counsel & Corporate Secretary", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 845500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher K. Mutz", "age": 53, "title": "Senior VP & Head of Rare Disease", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 919663, "exercisedValue": 0, "unexercisedValue": 602315}, {"maxAge": 1, "name": "Mr. Ori  Gutwerg", "age": 50, "title": "Senior Vice President of Generics", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 930962, "exercisedValue": 0, "unexercisedValue": 160630}, {"maxAge": 1, "name": "Mr. Muthusamy  Shanmugam MS R.Ph.", "age": 56, "title": "Head of R&D, COO of New Jersey Operations & Director", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elizabeth  Powell J.D.", "title": "Chief Compliance Officer & Head of Legal of Rare Disease", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chad  Gassert", "age": 48, "title": "Senior Vice President of Corporate Development & Strategy", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 849711, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Krista L. Davis", "age": 51, "title": "Senior VP & Chief Human Resources Officer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mary  Pao M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 2, "compensationRisk": 4, "shareHolderRightsRisk": 1, "overallRisk": 2, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.biosantepharma.com/SEC-Filings.php", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 82.13, "open": 82.32, "dayLow": 79.98, "dayHigh": 82.9999, "regularMarketPreviousClose": 82.13, "regularMarketOpen": 82.32, "regularMarketDayLow": 79.98, "regularMarketDayHigh": 82.9999, "payoutRatio": 0.0, "beta": 0.484, "trailingPE": 50.243748, "forwardPE": 9.42874, "volume": 406240, "regularMarketVolume": 406240, "averageVolume": 373953, "averageVolume10days": 338800, "averageDailyVolume10Day": 338800, "bid": 80.04, "ask": 80.66, "bidSize": 1, "askSize": 1, "marketCap": 1805412096, "fiftyTwoWeekLow": 52.5, "fiftyTwoWeekHigh": 99.5, "allTimeHigh": 450.0, "allTimeLow": 4.8, "priceToSalesTrailing12Months": 2.1834028, "fiftyDayAverage": 87.8864, "twoHundredDayAverage": 75.9357, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2040597120, "profitMargins": 0.04907, "floatShares": 18854723, "sharesOutstanding": 22458168, "sharesShort": 2846459, "sharesShortPriorMonth": 2504638, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.1267, "heldPercentInsiders": 0.09996, "heldPercentInstitutions": 0.97751, "shortRatio": 5.73, "shortPercentOfFloat": 0.1579, "impliedSharesOutstanding": 22458168, "bookValue": 24.192, "priceToBook": 3.3229995, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": 34148000, "trailingEps": 1.6, "forwardEps": 8.52606, "lastSplitFactor": "1:6", "lastSplitDate": 1374105600, "enterpriseToRevenue": 2.468, "enterpriseToEbitda": 14.067, "52WeekChange": 0.45723915, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 80.39, "targetHighPrice": 121.0, "targetLowPrice": 90.0, "targetMeanPrice": 109.25, "targetMedianPrice": 112.5, "recommendationMean": 1.625, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 271468992, "totalCashPerShare": 12.986, "ebitda": 145067008, "totalDebt": 631580032, "quickRatio": 1.937, "currentRatio": 2.581, "totalRevenue": 826880000, "debtToEquity": 124.863, "revenuePerShare": 41.885, "returnOnAssets": 0.02489, "returnOnEquity": 0.08663, "grossProfits": 502335008, "freeCashflow": 117813128, "operatingCashflow": 170718000, "revenueGrowth": 0.536, "grossMargins": 0.60751, "ebitdaMargins": 0.17544001, "operatingMargins": 0.10198, "financialCurrency": "USD", "symbol": "ANIP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "ANI Pharmaceuticals, Inc.", "epsTrailingTwelveMonths": 1.6, "epsForward": 8.52606, "epsCurrentYear": 7.5234, "priceEpsCurrentYear": 10.6853285, "fiftyDayAverageChange": -7.496399, "fiftyDayAverageChangePercent": -0.08529646, "twoHundredDayAverageChange": 4.4543, "twoHundredDayAverageChangePercent": 0.05865884, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "regularMarketChangePercent": -2.11859, "regularMarketPrice": 80.39, "marketState": "CLOSED", "longName": "ANI Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 957533400000, "postMarketChangePercent": 0.0, "postMarketPrice": 80.39, "postMarketChange": 0.0, "regularMarketChange": -1.74, "regularMarketDayRange": "79.98 - 82.9999", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 373953, "fiftyTwoWeekLowChange": 27.89, "fiftyTwoWeekLowChangePercent": 0.5312381, "fiftyTwoWeekRange": "52.5 - 99.5", "fiftyTwoWeekHighChange": -19.11, "fiftyTwoWeekHighChangePercent": -0.1920603, "fiftyTwoWeekChangePercent": 45.723915, "earningsTimestamp": 1762522200, "earningsTimestampStart": 1762522200, "earningsTimestampEnd": 1762522200, "earningsCallTimestampStart": 1762522200, "earningsCallTimestampEnd": 1762522200, "isEarningsDateEstimate": false, "corporateActions": [], "postMarketTime": 1765580176, "regularMarketTime": 1765573200, "exchange": "NGM", "messageBoardId": "finmb_1528824", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "displayName": "ANI Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]